Home › Kanser sa Baga › Illinois › Bloomington
Pag-aaral pangklinika para sa Kanser sa Baga sa Bloomington, IL
9 pag-aaral para sa Kanser sa Baga ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Bloomington (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Nagre-recruitPhase 3
- Illinois CancerCare-Bloomington, Bloomington
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Nagre-recruitPhase 3
- Illinois CancerCare-Bloomington, Bloomington
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- Illinois CancerCare - Bloomington, Bloomington
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Carle BroMenn Outpatient Center, Bloomington
- Illinois CancerCare-Bloomington, Bloomington
- Carle BroMenn Medical Center, Normal · 2 mi ang layo
- at 1 pa
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- OSF Saint Joseph Medical Center, Bloomington
- Illinois CancerCare-Bloomington, Bloomington
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Illinois CancerCare-Bloomington, Bloomington
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2/3
- Illinois CancerCare-Bloomington, Bloomington
- Carle BroMenn Medical Center, Normal · 2 mi ang layo
- Carle Cancer Institute Normal, Normal · 2 mi ang layo
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Illinois CancerCare-Bloomington, Bloomington
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Nagre-recruitObservasyonal na pag-aaral
- Illinois CancerCare-Bloomington, Bloomington
- Carle BroMenn Medical Center, Normal · 2 mi ang layo
- Carle Cancer Institute Normal, Normal · 2 mi ang layo
Pag-aaral para sa Kanser sa Baga sa ibang lungsod
- Houston, TX78 pag-aaral
- Boston, MA62 pag-aaral
- New York City, NY60 pag-aaral
- Los Angeles, CA45 pag-aaral
- Washington, DC41 pag-aaral
- Chicago, IL41 pag-aaral
- Arlington, VA40 pag-aaral
- Nashville, TN40 pag-aaral
- Baltimore, MD40 pag-aaral
- St. Louis, MO39 pag-aaral
- Columbus, OH36 pag-aaral
- Philadelphia, PA36 pag-aaral
Iba pang pag-aaral sa Bloomington
- Non-Small Cell Lung Cancer11 pag-aaral
- Kanser sa Prostate7 pag-aaral
- Colorectal Cancer7 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg6 pag-aaral
- Kanser sa Suso5 pag-aaral
- Kanser sa Pancreas5 pag-aaral
- Melanoma5 pag-aaral
- Kanser ng Hipoparynk5 pag-aaral
- Kanser sa Larynx5 pag-aaral
- Kanser sa Bibig5 pag-aaral
- Acute Myeloid Leukemia4 pag-aaral
- Kanser sa Bato (Renal Cell Carcinoma)4 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.